Cipla Ltd. — Board/Management Information 2026

May 13, 2026

Cipla

$13^{\text{th}}$ May, 2026

(1) BSE Limited
Listing Department
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai - 400 001
Scrip Code: 500087

(2) National Stock Exchange of India Limited
Listing Department
Exchange Plaza, 5th floor,
Plot no. C/1, G Block, Bandra Kurla Complex,
Bandra (East), Mumbai - 400 051
Scrip Symbol: CIPLA

(3) SOCIETE DE LA BOURSE DE LUXEMBOURG
Societe Anonyme
35A Boulevard Joseph II,
L-1840 Luxembourg

Sub: Outcome of the Board meeting held on 13th May, 2026

Dear Sir/Madam,

Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ('SEBI Listing Regulations'), the Board of Directors of Cipla Limited ('the Company') at its meeting held today i.e., 13th May, 2026, has inter-alia:

1. Approved convening of 90th Annual General Meeting of the Company on Thursday, 25th June, 2026.
2. Approved the grant of stock options and the employee stock appreciation rights (ESARs) in terms of the Cipla Employee Stock Option Scheme 2013-A and the Cipla Employee Stock Appreciation Rights Scheme 2021. Details required under the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 have been provided in Annexure A.
3. Approved the appointment of M/s Joshi Apte & Associates, Cost Accountants (Firm Registration no. 000240) as Cost Auditors of the Company for FY 2026-27. Details required under Regulation 30 and Schedule III of the SEBI Listing Regulations, read with the SEBI Master Circular dated January 30, 2026, bearing reference number HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 and such other circulars as applicable ('SEBI Master Circular'), are set out below at Annexure B
4. Approved the appointment of Mr Sushrut Kulkarni as President & Global Chief – Integrated Product Development (IPD), member of Management Council and Senior Management Personnel (SMP) of the Company w.e.f. 18th May 2026. Details required under the SEBI Listing Regulations, read with the SEBI Master Circular have been provided in Annexure C.

Cipla Ltd.
Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India
P +91 22 41916000 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Number L24239MH1935PLC002380

---

Cipla

The Board meeting of the Company which commenced today at 9:45 a.m. (IST) has concluded at 1:00 p.m. (IST).

The above-mentioned documents will also be available on the Company's website at www.cipla.com in the Investors Section.

Kindly take the above information on record.

Thanking you,

Yours faithfully,

For Cipla Limited

RAJENDR A CHOPRA

Digitally signed by RAJENDRA CHOPRA
Date: 2026.05.13 13:03:54 +05'30'

Rajendra Chopra
Company Secretary

Encl: As above

Prepared by: Neelam Padwad

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India

P +91 22 41916000 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Number L24239MH1935PLC002380

---

Cipla

Annexure A

Grants made in terms of the Employee Stock Option Scheme 2013-A ("ESOS 2013-A") and the Cipla Employee Stock Appreciation Rights Scheme 2021 ("ESAR 2021") under the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021:

S. N.	Scheme	Type of Option	No. of options / ESARs granted	Vesting period / date	Exercise period
1	ESOS 2013-A	Stock options*	25,323	1 year from the grant date	5 years from vesting date
			1,51,066	2 years from the grant date
2	ESAR 2021	Employee Stock Appreciation Rights (ESARs)**	4,74,589	3 years graded vesting	5 years from vesting date
			1,21,655	1 year from the grant date

• Exercise price INR 2 per stock option
  ** Exercise price INR 2 per equity share

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India

P +91 22 41916000 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Number L24239MH1935PLC002380

---

Cipla

Annexure B

Details as per the SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated

$30^{\text{th}}$ January, 2026

Name	M/s Joshi Apte & Associates, Cost Accountants (Firm Registration no. 000240)
Reason for change viz.—appointment, resignation, removal, death or otherwise	Appointment as Cost Auditors of the Company for FY 2026-27
Date of Appointment/cessation and terms of appointment
Brief Profile (in case of appointment)	M/s Joshi Apte & Associates is a firm of Practicing Cost Accounts. The firm was established 16 years back by experienced, like-minded professionals and is serving the clients since. They offer services in the domain of Cost and Management Accounting and beyond. The core strength of the firm lies in its team, which is a perfect blend of seasoned experts and dynamic young professionals. This combination enables the firm to deliver services with the highest level of professionalism. M/s Joshi Apte & Associates is committed to providing value addition to its clients through a dedicated and meticulous approach.
Disclosure of relationship between directors (in case of appointment of a director)	Not applicable.

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India

P +91 22 41916000 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Number L24239MH1935PLC002380

---

Cipla

Annexure C
Details as per the SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated
30th January, 2026

Name	Mr Sushrut Kulkarni
Reason for change viz. appointment, resignation, removal, death or otherwise	Appointed as Global Chief – Integrated Product Development, member of the Management Council and Senior Management Personnel of the Company w.e.f. 18th May, 2026
Date of appointment / cessation & term of appointment	Terms of appointment: Full-time employment
Brief Profile (in case of appointment)	Mr Sushrut Kulkarni has been appointed as President & Global Chief – Integrated Product Development (IPD) at Cipla Limited and is also a member of the Company’s Management Council.
Prior to joining Cipla, Sushrut served as the Global Head – Integrated Product Development Organization (IPDO) and a member of the Management Council at Dr Reddy’s Laboratories. Over the course of his three-decade-long career, he has held senior leadership roles with Glenmark & Zydus Lifesciences. Earlier in his career, he has also held positions of responsibility at Torrent Research Centre, Sandoz India, and Rhone Poulenc (India) Limited. With a strong track record of multiple filings and approvals across regulated and semi-regulated markets across diverse dosage forms, Sushrut has consistently demonstrated the ability to scale R&D operations, unlock stalled pipelines, and successfully execute complex programs in highly regulated markets.
Sushrut holds a Bachelor’s & Master’s degree in Pharmacy from Shivaji University & University of Mumbai respectively. Outside of work, he enjoys reading on history, autobiographies and spirituality, and is passionate about fitness, writing, photography and driving.
Disclosure of relationships between directors (in case of appointment of a director)	Not applicable.

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India

P +91 22 41916000 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Number L24239MH1935PLC002380